Literature DB >> 15055412

Factors affecting the detection rate of human papillomavirus.

Diane M Harper1, Meghan R Longacre, Walter W Noll, Dorothy R Belloni, Bernard F Cole.   

Abstract

BACKGROUND: Maximizing the accuracy of human papillomavirus (HPV) detection from a single sample is important for clinical and research purposes. The purpose of this study was to determine whether cyclic hormonal variation, recent sexual intercourse, interval between samplings, and the technique used to sample affect the detection of HPV.
METHODS: This study was a prospective, longitudinal, randomized controlled trial. Three techniques for self-sampling (2 consecutive synthetic polyester fiber [Dacron] swabs, a single Dacron swab, and a tampon) were repeated at 3 different sampling times during a period of 4 to 6 weeks in addition to 1 clinician-directed sampling of the ectocervix and endocervix at the first sampling time. All self-samplings were taken in a proscribed randomized order. Women (aged 18 to 68 years) attending a colposcopy clinic for abnormal cytology or abnormal cervical appearance participated in the study. The outcome measure was the detection of HPV by polymerase chain reaction amplification.
RESULTS: The 103 participants provided 1,189 cervicovaginal samplings. Logistic regression indicated that intercourse within 48 hours of sampling did not result in a greater detection of high-risk or any HPV type (odds ratio [OR] = 1.05, 95% confidence interval [CI], 0.65-1.69; OR = 1.08, 95% CI, 0.73-1.60, respectively). Among those women who have regular menstrual cycles, there was no cyclic effect on HPV detection for high-risk and any HPV types. Time from previous sampling did not affect HPV detection. Among the self-sampling techniques, using a single self-swab and the tampon resulted in the detection of HPV between 10% and 35% less often than using 2 consecutive swabs (P < .025). Self-sampling with 2 swabs was not significantly different from clinician sampling for detecting high-risk HPV types (OR for self-sampling = 0.87 (95% CI, 0.66-1.13)).
CONCLUSIONS: HPV detection is not dependent on menstrual cycle timings, the recency of intercourse, or the time between samplings, but it is dependent on the sampling technique.

Entities:  

Mesh:

Year:  2003        PMID: 15055412      PMCID: PMC1466609          DOI: 10.1370/afm.90

Source DB:  PubMed          Journal:  Ann Fam Med        ISSN: 1544-1709            Impact factor:   5.166


  35 in total

1.  Human papillomavirus testing for primary cervical cancer screening.

Authors:  J Cuzick
Journal:  JAMA       Date:  2000-01-05       Impact factor: 56.272

2.  Adjunctive testing for cervical cancer in low resource settings with visual inspection, HPV, and the Pap smear.

Authors:  P D Blumenthal; L Gaffikin; Z M Chirenje; J McGrath; S Womack; K Shah
Journal:  Int J Gynaecol Obstet       Date:  2001-01       Impact factor: 3.561

3.  Evaluation of a human papillomavirus assay in cervical screening in Zimbabwe.

Authors:  S D Womack; Z M Chirenje; P D Blumenthal; L Gaffikin; J A McGrath; T Chipato; E Ngwalle; K V Shah
Journal:  BJOG       Date:  2000-01       Impact factor: 6.531

Review 4.  Clinical studies of human papilloma vaccines in pre-invasive and invasive cancer.

Authors:  M Adams; L Borysiewicz; A Fiander; S Man; B Jasani; H Navabi; C Lipetz; A S Evans; M Mason
Journal:  Vaccine       Date:  2001-03-21       Impact factor: 3.641

5.  Estimating the prevalence of Trichomonas vaginalis, Chlamydia trachomatis, Neisseria gonorrhoeae, and human papillomavirus infection in indigenous women in northern Australia.

Authors:  F J Bowden; B A Paterson; J Mein; J Savage; C K Fairley; S M Garland; S N Tabrizi
Journal:  Sex Transm Infect       Date:  1999-12       Impact factor: 3.519

6.  Diagnosis of urogenital Chlamydia trachomatis infection in women based on mailed samples obtained at home: multipractice comparative study.

Authors:  L Ostergaard; J K Møller; B Andersen; F Olesen
Journal:  BMJ       Date:  1996-11-09

7.  Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia.

Authors:  G Y Ho; R D Burk; S Klein; A S Kadish; C J Chang; P Palan; J Basu; R Tachezy; R Lewis; S Romney
Journal:  J Natl Cancer Inst       Date:  1995-09-20       Impact factor: 13.506

8.  Repeated evaluation of human papillomavirus 16 status in cervical swabs of young women with a history of normal Papanicolaou smears.

Authors:  A Schneider; T Kirchhoff; G Meinhardt; L Gissmann
Journal:  Obstet Gynecol       Date:  1992-05       Impact factor: 7.661

9.  Tampons: a novel patient-administered method for the assessment of genital human papillomavirus infection.

Authors:  C K Fairley; S Chen; S N Tabrizi; M A Quinn; J J McNeil; S M Garland
Journal:  J Infect Dis       Date:  1992-06       Impact factor: 5.226

10.  Contraceptive and reproductive risks for cervical dysplasia in southwestern Hispanic and non-Hispanic white women.

Authors:  T M Becker; C M Wheeler; N S McGough; C A Stidley; C A Parmenter; M H Dorin; S W Jordan
Journal:  Int J Epidemiol       Date:  1994-10       Impact factor: 7.196

View more
  13 in total

1.  Short-term natural history of high-risk human papillomavirus infection in mid-adult women sampled monthly.

Authors:  Tsung-chieh Jane Fu; Long Fu Xi; Ayaka Hulbert; James P Hughes; Qinghua Feng; Stephen M Schwartz; Stephen E Hawes; Laura A Koutsky; Rachel L Winer
Journal:  Int J Cancer       Date:  2015-05-29       Impact factor: 7.396

2.  [Self-collection of test material. Supplement to cervical cancer screening].

Authors:  B R Mangold
Journal:  Pathologe       Date:  2013-11       Impact factor: 1.011

3.  Acceptability and usability of self-collected sampling for HPV testing among African-American women living in the Mississippi Delta.

Authors:  Isabel C Scarinci; Allison G Litton; Isabel C Garcés-Palacio; Edward E Partridge; Philip E Castle
Journal:  Womens Health Issues       Date:  2013-02-12

4.  Menstrual cycle and detectable human papillomavirus in reproductive-age women: a time series study.

Authors:  Su-Hsun Liu; Rebecca M Brotman; Jonathan M Zenilman; Patti E Gravitt; Derek A T Cummings
Journal:  J Infect Dis       Date:  2013-07-24       Impact factor: 5.226

5.  Prevalence and risk factors for oncogenic human papillomavirus infections in high-risk mid-adult women.

Authors:  Rachel L Winer; James P Hughes; Qinghua Feng; Long Fu Xi; Shu-Kuang Lee; Sandra F O'Reilly; Nancy B Kiviat; Laura A Koutsky
Journal:  Sex Transm Dis       Date:  2012-11       Impact factor: 2.830

6.  Epidemiology of Human Papillomavirus Detected in the Oral Cavity and Fingernails of Mid-Adult Women.

Authors:  Tsung-chieh Jane Fu; James P Hughes; Qinghua Feng; Ayaka Hulbert; Stephen E Hawes; Long Fu Xi; Stephen M Schwartz; Joshua E Stern; Laura A Koutsky; Rachel L Winer
Journal:  Sex Transm Dis       Date:  2015-12       Impact factor: 2.830

7.  Cervical human papillomavirus detection is not affected by menstrual phase.

Authors:  Joseph E Tota; Agnihotram V Ramanakumar; Salaheddin M Mahmud; Andrea Trevisan; Luisa L Villa; Eduardo L Franco
Journal:  Sex Transm Infect       Date:  2012-10-30       Impact factor: 3.519

8.  Assessing Acceptability of Self-Sampling Kits, Prevalence, and Risk Factors for Human Papillomavirus Infection in American Indian Women.

Authors:  Rachel L Winer; Angela A Gonzales; Carolyn J Noonan; Stephen L Cherne; Dedra S Buchwald
Journal:  J Community Health       Date:  2016-10

9.  Extended HPV Genotyping to Compare HPV Type Distribution in Self- and Provider-Collected Samples for Cervical Cancer Screening.

Authors:  Eliane Rohner; Claire Edelman; Busola Sanusi; John W Schmitt; Anna Baker; Kirsty Chesko; Brian Faherty; Sean M Gregory; LaHoma S Romocki; Vijay Sivaraman; Julie A E Nelson; Siobhan O'Connor; Michael G Hudgens; Andrea K Knittel; Lisa Rahangdale; Jennifer S Smith
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2020-09-17       Impact factor: 4.254

10.  Investigating a cluster of vulvar cancer in young women: a cross-sectional study of genital human papillomavirus prevalence.

Authors:  Alice R Rumbold; Sarah E Tan; John R Condon; Debbie Taylor-Thomson; Maria Nickels; Sepehr N Tabrizi; Margaret L J Davy; Margaret M O'Brien; Christine M Connors; Ibrahim Zardawi; Jim Stankovich; Suzanne M Garland
Journal:  BMC Infect Dis       Date:  2012-10-05       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.